In October 2019, Benjamin-Alexandre Jeanroy, CEO of Augur Associates, a Paris-based marijuana consultancy firm, alerted Marijuana Business Daily about the importance of the budget, saying “it’s very important that funding for the medical cannabis experiment is now integrated into this process.”
Augur’s Jeanroy told MJBizDaily that “another version of the parliamentary committee report is expected in early 2021, which will also include wellness and adult-use dimensions.”
Continuer à lire sur Marijuana Business Daily.